Drugs / LCIG
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02604914 Comparator | May 2015 → Jun 2016 | Parkinson disease | NeuroDerm Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LCIG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02604914 ↗ |
| Route | Other | “directly to the jejunum” NCT02604914 ↗ |